Abstract
Global concern about problematic usage of the internet (PUI), and its public health and societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 pandemic. This narrative review reports the expert opinions of members of the largest international network of researchers on PUI in the framework of the European Cooperation in Science and Technology (COST) Action (CA 16207), on the scientific progress made and the critical knowledge gaps remaining to be filled as the term of the Action reaches its conclusion. A key advance has been achieving consensus on the clinical definition of various forms of PUI. Based on the overarching public health principles of protecting individuals and the public from harm and promoting the highest attainable standard of health, the World Health Organisation has introduced several new structured diagnoses into the ICD-11, including gambling disorder, gaming disorder, compulsive sexual behaviour disorder, and other unspecified or specified disorders due to addictive behaviours, alongside naming online activity as a diagnostic specifier. These definitions provide for the first time a sound platform for developing systematic networked research into various forms of PUI at global scale. Progress has also been made in areas such as refining and simplifying some of the available assessment instruments, clarifying the underpinning brain-based and social determinants, and building more empirically based etiological models, as a basis for therapeutic intervention, alongside public engagement initiatives. However, important gaps in our knowledge remain to be tackled. Principal among these include a better understanding of the course and evolution of the PUI-related problems, across different age groups, genders and other specific vulnerable groups, reliable methods for early identification of individuals at risk (before PUI becomes disordered), efficacious preventative and therapeutic interventions and ethical health and social policy changes that adequately safeguard human digital rights. The paper concludes with recommendations for achievable research goals, based on longitudinal analysis of a large multinational cohort co-designed with public stakeholders.
| Original language | English (US) |
|---|---|
| Article number | 152346 |
| Journal | Comprehensive Psychiatry |
| Volume | 118 |
| DOIs | |
| State | Published - Oct 2022 |
Keywords
- Behavioral addiction
- Compulsive
- Covid-19 pandemic
- Gaming disorder
- Impulsive
- Patient and public involvement (PPI)
- Problematic usage of the Internet
ASJC Scopus subject areas
- Clinical Psychology
- Psychiatry and Mental health
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Advances in problematic usage of the internet research – A narrative review by experts from the European network for problematic usage of the internet'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Comprehensive Psychiatry, Vol. 118, 152346, 10.2022.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Advances in problematic usage of the internet research – A narrative review by experts from the European network for problematic usage of the internet
AU - Fineberg, Naomi A.
AU - Menchón, José M.
AU - Hall, Natalie
AU - Dell'Osso, Bernardo
AU - Brand, Matthias
AU - Potenza, Marc N.
AU - Chamberlain, Samuel R.
AU - Cirnigliaro, Giovanna
AU - Lochner, Christine
AU - Billieux, Joël
AU - Demetrovics, Zsolt
AU - Rumpf, Hans Jürgen
AU - Müller, Astrid
AU - Castro-Calvo, Jesús
AU - Hollander, Eric
AU - Burkauskas, Julius
AU - Grünblatt, Edna
AU - Walitza, Susanne
AU - Corazza, Ornella
AU - King, Daniel L.
AU - Stein, Dan J.
AU - Grant, Jon E.
AU - Pallanti, Stefano
AU - Bowden-Jones, Henrietta
AU - Ameringen, Michael Van
AU - Ioannidis, Konstantinos
AU - Carmi, Lior
AU - Goudriaan, Anna E.
AU - Martinotti, Giovanni
AU - Sales, Célia M.D.
AU - Jones, Julia
AU - Gjoneska, Biljiana
AU - Király, Orsolya
AU - Benatti, Beatrice
AU - Vismara, Matteo
AU - Pellegrini, Luca
AU - Conti, Dario
AU - Cataldo, Ilaria
AU - Riva, Gianluigi M.
AU - Yücel, Murat
AU - Flayelle, Maèva
AU - Hall, Thomas
AU - Griffiths, Morgan
AU - Zohar, Joseph
N1 - Funding Information: Zsolt Demetrovics's contribution was supported by the Hungarian National Research, Development and Innovation Office ( KKP126835 , K134807 ). Orsolya Király's contribution was supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences and by the ÚNKP-21-5 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund. ELTE Eötvös Loránd University receives funding from the Szerencsejáték Ltd . to maintain a telephone helpline service for problematic gambling. Zsolt Demetrovics has also been involved in research on responsible gambling funded by Szerencsejáték Ltd . and the Gambling Supervision Board and provided educational materials for the Szerencsejáték Ltd.'s responsible gambling program. The University of Gibraltar receives funding from the Gibraltar Gambling Care Foundation . However, these funding aren't related to this study and the funding institution had no role in the study design or the collection, analysis, and interpretation of the data, writing the manuscript, or the decision to submit the paper for publication. Funding Information: Sam Chamberlain's research was funded by a Wellcome Trust Clinical Fellowship ( 110049/Z/15/Z & 110049/Z/15/A ). He receives honoraria from Elsevier for editorial work. Funding Information: Murat Yücel's role on this paper was funded through a National Health and Medical Research Council Fellowship (NHMRC; # APP1117188 ). Murat Yücel also receives funding from other NHMRC schemes , Monash University , and Australian Government funding bodies such as the Australian Research Council (ARC), Australian Defense Science and Technology (DST), and the Department of Industry, Innovation and Science (DIIS). He has also received philanthropic donations from the David Winston Turner Endowment Fund , Wilson Foundation , as well as payments in relation to court-, expert witness-, and/or expert review-reports. Finally, he has received funding to conduct sponsored Investigator-Initiated trials (including Incannex Healthcare Ltd ). These funding sources had no role in the design, management, data analysis, presentation, or interpretation and write-up of the data. Funding Information: The authors wish to acknowledge the members of the International College of Obsessive-Compulsive Disorders ( http://www.ICOCS.org ) who have contributed to the development of this manuscript. We are grateful to members of the European College of Neuropsychopharmacology (ECNP) Obsessive Compulsive and Related Disorders Research Network (OCRN) whose comments have shaped this manuscript in its development. The ECNP OCRN is component of the ECNP-Network Initiative (ECNP-NI) and receives financial support from the ECNP , to support its academic activities. We thank the members of the public, young people and parents/carers who have collaborated with this COST ACTION, including the PUI Festival and the PUI Companion Book, with particular thanks to Thomas Hall and Morgan Griffiths for their valued support and contribution to our work. We also would like to thank the early career network on PUI which now counts over 60 early career scholars, and it is one of the legacies of our COST ACTION. Funding Information: Naomi Fineberg reports research grants from UK National Institute for Health Research (NIHR), Orchard OCD , European COST Action , royalties/licenses from Oxford university press , payment or honoraria for lectures/presentations/speakers bureaus/manuscript writing/educational events from Global Mental Health Academy. She also received support for attending meetings and/or travel from British Association for Psychopharmacology, European College for Neuropsychopharmacology (ECNP), Royal College of Psychiatrists, International College for Neuropsychopharmacology, European COST Action, World Psychiatric Association, International Forum for Mood and Anxiety disorders, American College for Neuropsychopharmacology. She is/was also chair in the ECNP Review Board and in the World Psychiatric Association scientific section for OCD and anxiety, she is the secretary of the International College of Obsessive Compulsive Spectrum disorders and board member of the Orchard advancing research in OCD. She leads a national OCD treatment service. She is the editor in chief for Comprehensive Psychiatry journal. She gives expert advice on psychopharmacology to the UK Medicines and Healthcare products Regulatory Agency (MHRA). Funding Information: Matthias Brand (to University of Duisburg-Essen), Astrid Müller (to Hannover Medical School) and Hans-Jürgen Rumpf (to University of Lübeck) receive grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) in the context of the Research Unit FOR 2974 Affective and cognitive mechanisms of specific Internet-use disorders (project number 411232260). Funding Information: Jose M Menchon has received research or networking funding from the Spanish official research agencies CIBERSAM-ISCIII and AGAUR , has received consultation fees from Janssen, lecture fees from AbBiotics, Exeltis, and research funding from Janssen, AbBiotics, Novartis, and Medtronic in the last 36 months. Funding Information: Stefano Pallanti has received research grant (GRANT NIH R21 DA042271-01A1 “Modulating Inhibitory Control Networks in Gambling Disorders with Theta-Burst Stimulation”). Funding Information: Jon E Grant has received research grants from the TLC Foundation for Body-Focused Repetitive Behaviours , and Otsuka , Biohaven , and Avanir Pharmaceuticals . He receives yearly compensation for acting as editor-in-chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Inc., Norton Press, and McGraw Hill. Funding Information: This publication is based upon work from COST Action CA16207 “European Network for Problematic Usage of the Internet”, supported by COST (European Cooperation in Science and Technology, http://www.cost.eu).Naomi Fineberg reports research grants from UK National Institute for Health Research (NIHR), Orchard OCD, European COST Action, royalties/licenses from Oxford university press, payment or honoraria for lectures/presentations/speakers bureaus/manuscript writing/educational events from Global Mental Health Academy. She also received support for attending meetings and/or travel from British Association for Psychopharmacology, European College for Neuropsychopharmacology (ECNP), Royal College of Psychiatrists, International College for Neuropsychopharmacology, European COST Action, World Psychiatric Association, International Forum for Mood and Anxiety disorders, American College for Neuropsychopharmacology. She is/was also chair in the ECNP Review Board and in the World Psychiatric Association scientific section for OCD and anxiety, she is the secretary of the International College of Obsessive Compulsive Spectrum disorders and board member of the Orchard advancing research in OCD. She leads a national OCD treatment service. She is the editor in chief for Comprehensive Psychiatry journal. She gives expert advice on psychopharmacology to the UK Medicines and Healthcare products Regulatory Agency (MHRA).Jose M Menchon has received research or networking funding from the Spanish official research agencies CIBERSAM-ISCIII and AGAUR, has received consultation fees from Janssen, lecture fees from AbBiotics, Exeltis, and research funding from Janssen, AbBiotics, Novartis, and Medtronic in the last 36 months.Matthias Brand (to University of Duisburg-Essen), Astrid Müller (to Hannover Medical School) and Hans-Jürgen Rumpf (to University of Lübeck) receive grants from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) in the context of the Research Unit FOR 2974 Affective and cognitive mechanisms of specific Internet-use disorders (project number 411232260).Sam Chamberlain's research was funded by a Wellcome Trust Clinical Fellowship (110049/Z/15/Z & 110049/Z/15/A). He receives honoraria from Elsevier for editorial work.Zsolt Demetrovics's contribution was supported by the Hungarian National Research, Development and Innovation Office (KKP126835, K134807). Orsolya Király's contribution was supported by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences and by the ÚNKP-21-5 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund. ELTE Eötvös Loránd University receives funding from the Szerencsejáték Ltd. to maintain a telephone helpline service for problematic gambling. Zsolt Demetrovics has also been involved in research on responsible gambling funded by Szerencsejáték Ltd. and the Gambling Supervision Board and provided educational materials for the Szerencsejáték Ltd.'s responsible gambling program. The University of Gibraltar receives funding from the Gibraltar Gambling Care Foundation. However, these funding aren't related to this study and the funding institution had no role in the study design or the collection, analysis, and interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.Eric Hollander receives Research Grants from Department of Defense, Orphan Products Division of Food and Drug Administration, Roche, GW Pharma. He has consulted from Roche, GW Pharma and he receives editorial fees from Elsevier.Daniel L King has received research funds from the Australian Research Council, Victorian Responsible Gambling Foundation, European Association for the Study of Gambling, National Association for Gambling Studies and the World Health Organisation. He declares no conflicts of interest in relation to this manuscript.Jon E Grant has received research grants from the TLC Foundation for Body-Focused Repetitive Behaviours, and Otsuka, Biohaven, and Avanir Pharmaceuticals. He receives yearly compensation for acting as editor-in-chief of the Journal of Gambling Studies and has received royalties from Oxford University Press, American Psychiatric Publishing, Inc., Norton Press, and McGraw Hill.Michael Van Ameringen reports being on the Advisory Boards of Allergan, Almatica, Brainsway, Lundbeck, Otsuka, Purdue Pharma (Canada), Tilray and Vistagen; he is on the Speaker's Bureau for Allergan, Lundbeck, Purdue Pharma (Canada), Otsuka, Pfizer and Takeda; he has received research support from Purdue Pharma (Canada), the Canadian Foundation for Innovation and Hamilton Academic Health Sciences Organisation (HAHSO) and honoraria from UpToDate.Anna E Goudriaan reports ZonMw grant VIDI scheme #91713354.Murat Yücel's role on this paper was funded through a National Health and Medical Research Council Fellowship (NHMRC; #APP1117188). Murat Yücel also receives funding from other NHMRC schemes, Monash University, and Australian Government funding bodies such as the Australian Research Council (ARC), Australian Defense Science and Technology (DST), and the Department of Industry, Innovation and Science (DIIS). He has also received philanthropic donations from the David Winston Turner Endowment Fund, Wilson Foundation, as well as payments in relation to court-, expert witness-, and/or expert review-reports. Finally, he has received funding to conduct sponsored Investigator-Initiated trials (including Incannex Healthcare Ltd). These funding sources had no role in the design, management, data analysis, presentation, or interpretation and write-up of the data.Joseph Zohar has received grants or research supports from Lundbeck, Servier, Brainsway & Pfizer, NIH, DoD. He has received honoraria or consultation fees from Servier, Pfizer, Abbott, Lilly, Actelion, AstraZeneca, SunPharma, Roche and Brainsway. He participates in company sponsored: Lundbeck, Roche, Lilly, Servier, Pfizer. He is in the speaker's bureau for Abbott, SunPharma and Brainsway.The authors wish to acknowledge the members of the International College of Obsessive-Compulsive Disorders (http://www.ICOCS.org) who have contributed to the development of this manuscript. We are grateful to members of the European College of Neuropsychopharmacology (ECNP) Obsessive Compulsive and Related Disorders Research Network (OCRN) whose comments have shaped this manuscript in its development. The ECNP OCRN is component of the ECNP-Network Initiative (ECNP-NI) and receives financial support from the ECNP, to support its academic activities. We thank the members of the public, young people and parents/carers who have collaborated with this COST ACTION, including the PUI Festival and the PUI Companion Book, with particular thanks to Thomas Hall and Morgan Griffiths for their valued support and contribution to our work. We also would like to thank the early career network on PUI which now counts over 60 early career scholars, and it is one of the legacies of our COST ACTION. Funding Information: Joseph Zohar has received grants or research supports from Lundbeck , Servier , Brainsway & Pfizer , NIH , DoD . He has received honoraria or consultation fees from Servier, Pfizer, Abbott, Lilly, Actelion, AstraZeneca, SunPharma, Roche and Brainsway. He participates in company sponsored: Lundbeck, Roche, Lilly, Servier, Pfizer. He is in the speaker's bureau for Abbott, SunPharma and Brainsway. Funding Information: Daniel L King has received research funds from the Australian Research Council , Victorian Responsible Gambling Foundation , European Association for the Study of Gambling , National Association for Gambling Studies and the World Health Organisation . He declares no conflicts of interest in relation to this manuscript. Publisher Copyright: © 2022 The Authors
PY - 2022/10
Y1 - 2022/10
N2 - Global concern about problematic usage of the internet (PUI), and its public health and societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 pandemic. This narrative review reports the expert opinions of members of the largest international network of researchers on PUI in the framework of the European Cooperation in Science and Technology (COST) Action (CA 16207), on the scientific progress made and the critical knowledge gaps remaining to be filled as the term of the Action reaches its conclusion. A key advance has been achieving consensus on the clinical definition of various forms of PUI. Based on the overarching public health principles of protecting individuals and the public from harm and promoting the highest attainable standard of health, the World Health Organisation has introduced several new structured diagnoses into the ICD-11, including gambling disorder, gaming disorder, compulsive sexual behaviour disorder, and other unspecified or specified disorders due to addictive behaviours, alongside naming online activity as a diagnostic specifier. These definitions provide for the first time a sound platform for developing systematic networked research into various forms of PUI at global scale. Progress has also been made in areas such as refining and simplifying some of the available assessment instruments, clarifying the underpinning brain-based and social determinants, and building more empirically based etiological models, as a basis for therapeutic intervention, alongside public engagement initiatives. However, important gaps in our knowledge remain to be tackled. Principal among these include a better understanding of the course and evolution of the PUI-related problems, across different age groups, genders and other specific vulnerable groups, reliable methods for early identification of individuals at risk (before PUI becomes disordered), efficacious preventative and therapeutic interventions and ethical health and social policy changes that adequately safeguard human digital rights. The paper concludes with recommendations for achievable research goals, based on longitudinal analysis of a large multinational cohort co-designed with public stakeholders.
AB - Global concern about problematic usage of the internet (PUI), and its public health and societal costs, continues to grow, sharpened in focus under the privations of the COVID-19 pandemic. This narrative review reports the expert opinions of members of the largest international network of researchers on PUI in the framework of the European Cooperation in Science and Technology (COST) Action (CA 16207), on the scientific progress made and the critical knowledge gaps remaining to be filled as the term of the Action reaches its conclusion. A key advance has been achieving consensus on the clinical definition of various forms of PUI. Based on the overarching public health principles of protecting individuals and the public from harm and promoting the highest attainable standard of health, the World Health Organisation has introduced several new structured diagnoses into the ICD-11, including gambling disorder, gaming disorder, compulsive sexual behaviour disorder, and other unspecified or specified disorders due to addictive behaviours, alongside naming online activity as a diagnostic specifier. These definitions provide for the first time a sound platform for developing systematic networked research into various forms of PUI at global scale. Progress has also been made in areas such as refining and simplifying some of the available assessment instruments, clarifying the underpinning brain-based and social determinants, and building more empirically based etiological models, as a basis for therapeutic intervention, alongside public engagement initiatives. However, important gaps in our knowledge remain to be tackled. Principal among these include a better understanding of the course and evolution of the PUI-related problems, across different age groups, genders and other specific vulnerable groups, reliable methods for early identification of individuals at risk (before PUI becomes disordered), efficacious preventative and therapeutic interventions and ethical health and social policy changes that adequately safeguard human digital rights. The paper concludes with recommendations for achievable research goals, based on longitudinal analysis of a large multinational cohort co-designed with public stakeholders.
KW - Behavioral addiction
KW - Compulsive
KW - Covid-19 pandemic
KW - Gaming disorder
KW - Impulsive
KW - Patient and public involvement (PPI)
KW - Problematic usage of the Internet
UR - http://www.scopus.com/inward/record.url?scp=85136485402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136485402&partnerID=8YFLogxK
U2 - 10.1016/j.comppsych.2022.152346
DO - 10.1016/j.comppsych.2022.152346
M3 - Article
C2 - 36029549
AN - SCOPUS:85136485402
SN - 0010-440X
VL - 118
JO - Comprehensive Psychiatry
JF - Comprehensive Psychiatry
M1 - 152346
ER -